Liver and kidney function in patients with Covid‐19 treated with remdesivir

For the treatment of Covid‐19 patients with remdesivir, poor renal and liver function were both exclusion criteria in randomized clinical trials and contraindication for treatment. Also, nephrotoxicity and hepatotoxicity are reported as adverse events. We retrospectively reviewed renal and liver fun...

Descripción completa

Detalles Bibliográficos
Autores principales: van Laar, Sylvia A., de Boer, Mark G. J., Gombert‐Handoko, Kim B., Guchelaar, Henk‐Jan, Zwaveling, Juliette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251044/
https://www.ncbi.nlm.nih.gov/pubmed/33763917
http://dx.doi.org/10.1111/bcp.14831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251044/
https://www.ncbi.nlm.nih.gov/pubmed/33763917
http://dx.doi.org/10.1111/bcp.14831

Ejemplares similares